Kim Sablich, Chief Commercial Officer at Myovant Sciences Ltd. (MYOV), sold 785 shares at $7.38 ($6K) on 2020-03-18, disclosed to the SEC on 2020-03-19.
Open-market sale of $6k MYOV by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.93 | 15 | $104 | 1.8% |
| 2 | $7.38 | 770 | $6K | 98.2% |
| Total | $7.37 avg | 785 | $6K | 100% |
| Filing → |
| JAZZ | SELL | 2021-11-15 | $742K | — | Filing → |
| MYOV | SELL | 2020-01-16 | $136K | — | Filing → |
| MYOV | SELL | 2019-12-19 | $42K | — | Filing → |